on the GC mass spectrometer. They are investigating it at present. TOBIN: Model 2 assumes a single site from which absorbtion of an intramuscular injection occurs and there is a discrepancy. We can only account for about half the drug absorbed and we assume a single first order rate of absorption.
Introduction N,N-diethyinicotinamide (nikethamide) is a widely used respiratory stimulant for oral and parenteral use which is formulated alone or in multi-component pharmaceutical dosage forms.
After oral administration of nikethamide (CORA-MINER Ciba) to human beings, an unknown substance was isolated from the urine by means of extraction and TLC (thin layer chromatography) procedures. This substance was identified as N-ethylnicotinamide, an intermediate metabolite of nikethamide. The metabolism and excretion of nikethamide was followed in the horse after intramuscular injection, by means of qualitative and quantitative GLC measurements of both substances.
Several papers on thin layer chromatographic methods for the detection of nikethamide in biological materials have been published (1, 2, 3, 4) . Infra-red and ultra-violet spectrophotometric determination of the drug extracted from saliva following its isolation by TLC have also been described in connection with the control of doping in race-horses (5) . Qualitative gas liquid chromatographic determinations with a range of stationary phases have been published for nikethamide alone and in the presence of nicotinic acid (6, 7) . Quantitative essays of nikethamide in pharmaceutical dosage forms (8) and recently in injectable preparations (9) have been described using spectrophotometric and gas liquid chromatographic methods respectively.
Metabolism of Nikethamide
In 1974 the central nervous stimulant nikethamide was added to the list of forbidden drugs published by the Medical Commission of the International Cyclists Union. As our laboratory is also involved in the doping control of cyclists a study was undertaken to detect nikethamide in human urine. Using the extraction and TLC procedures already described in an earlier paper (4) and slightly modified as mentioned here we found that after oral administration of the drug a spot with an Rf value different from that of nikethamide occured on the silica gel plate.
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Since it is well known that nikethamide is metabolized finally to nicotinamide which is a normal physiological metabolite as well as a vitamin preparation, it was assumed that the additional spot resulted from the intermediate metabolite N-ethylnicotinamide ( Fig. 1) and that the presence of this compound could be used to prove a 'positive' nikethamide case. N-ethyinicotinamide was occasionally obtained during the synthesis of CORAMINER as a result of the presence of monoethylamine impurity in the diethylamine used. Nevertheless the two solvent systems used in the quantitative TLC determination (8) failed to separate this compound from nikethamide. After the administration of nikethamide to guinea-pigs, Chambon (10) using a spectrophotometric method detected only the water soluble N-oxide derivative of N,N-diethyinicotinamide. No nikethamide was found in the urine. Amine oxides of nicotinamide were also found in biological materials of rats (11) and mice (12, 13, 14, 15) . After the injection of nikethamide in horses the substance could be detected by a TLC method equally well in urine, blood and saliva but only up to 3 hours after its administration (4). The unchanged thionylchloride was distilled off and the contents of the flask washed with benzene, filtered and dried. The residue was then treated with a monoethylamine solution (70% in water), made alkaline with 50% sodium hydroxide solution and extracted with chloroform.
After evaporating the extract in vacuo, the resulting oil was redissolved in ether and purified by bubbling hydrochloric acid in the solution giving rise to the crystalline N-ethylnicotinamide hydrochloride. The structure of this derivative was confirmed by chemical ionization mass spectrometry. Field ionization mass spectrometry yielded the molecular ion peak at m/e 170.
Since the metabolite nicotinamide is a normal physiological substance and moreover very slightly soluble in g-N---C2 Urine (25 ml) was pipetted into a glass-stoppered tube. After adjusting the pH to 11-12 with a few drops of a 50% sodium hydroxide solution, the urine was extracted three times with chloroform (7 ml) using a mechanical shaker (20 minutes), centrifuged, and the organic phase separated. The combined chloroform extracts were then dried over anhydrous sodium sulphate, treated with 1 ml of an etheral solution of hydrochloric acid and evaporated to dryness in vacuo at 400C. For qualitative work the extract was transferred to a small tube using 1% diethylamine (1 ml) in ether and evaporated at ambient temperature. The extract was redissolved in chloroform, methanol or diethylether (20 jil) and gas chromatographed (1-2 Mil). For quantitative purposes 0.5 m internal standard solution (0.5 jig/ diethylamine:chloroform, 1:100) v% injected into the gas chromatogra graphy was performed using a VER' The conditions are described in ,ug/ml four urine samples for each concentration were extracted and gas chromatographed as described above. catheter into the bladder and blowing up the balloon with air, the catheter was connected to a plastic tube which conveyed the urine continuously into a plastic receptacl e.
After measuring the volume and the pH, 25 ml aliquots of the urine samples were immediately extracted in quadruplicate and gas chromatographed as described above.
Results and Discussion
The results of the experiments are summarized in Table I and II and a typical pattern in the excretion and metabolism is given in Figs. 5 and 6.
Excretion of Unchanged Nikethamide
The total amount of unchanged nikethamide excreted during the 9 hour-period after the injection showed very great individual variations between the six horses without ammonium chloride pretreatment. This was probably due partly to the difference in volume of urine excreted but also to the excretion rate of the product itself as can be seen from the average concentrations expressed in ,ug/ml. This varied between 1.8 and 6.79 Mg/ml or a 3-4 fold variation. at the beginning of the experiment. This was also the case for the total excretion (mg/hr) as well as for the concentration (mig/ml). After 5-6 hours the concentration of nikethamide reached a minimum value below the detection limit of 0,4 Mig/ml urine. Nevertheless, using the qualitative procedure described above a detection limit of 0.2 Mig/ml in urine was obtained resulting in a possible detection of nikethamide even after 6 hr.
The low percentage of unchanged drug excreted, together with the very quick disappearance of nikethamide from the urine suggest that nikethamide is metabolized very rapidly in the horse, in which case this should be confirmed by the excretion pattern of its metabolite N-ethyln icotinamide.
Excretion of N-ethylnicotinamide
For all the horses studied there was already a marked excretion of this metabolite 1 hr after the injection of nikethamide. Furthermore the rate of excretion of the metabolite as well as its concentration increased progressively to a maximum level at 3-4 hours after the injection. Thereafter the elimination and concentration curves showed a very slow decline so that even 12 hours after the injection pronounced quantities of the metabolite could still be detected (detection limit 1 jig/ml). This means that despite the rapid metabolism of nikethamide the elimination of one of its metabolites takes at least twice as long as for the original drug. Hence, in the control of doping in racehorses, a "positive" case for doping with nikethamide could easily be proved by means of the extraction and GLC procedures described, even 12 hours after the administration of the drug. This conclusion is only valid for urine samples and not for saliva. Indeed saliva samples have been examined with the same qualitative procedure up to 3 hours after the injection, but, despite nikethamide being detectable in urine up to 6 hours and N-ethylnicotinamide up to 12 hours after the injection, none of these substances could be detected in the saliva samples examined.
Nevertheless, except for two cases (horses Nos. 1 and 5) the maximum concentration of N-ethylnicotinamide was never higher than that for nikethamide. For the quantity of metabolite excreted per hour this was only the case in 2 of the 6 experiments (Nos. 2 and 4). The total amount of the metabolite eliminated within 12 hours after the injection was at least 1.5-2 times higher than for the original drug except for the horse No. 4 and this was due to a loss of urine during this experiment between 6 and 9 hrs. As for the unchanged drug itself the percentage of the original dose excreted as N-ethylnicotinamide was very low with a mean value of 0.34% (a = 0.116), although it must be emphasized that this percentage was at least twice as high as that for the original drug. This means that for a given dose of nikethamide the quantity of its metabolite N-ethyinicotinamide excreted is at least double that of the parent drug. It seems therefore that the total amount of nikethamide together with its metabolite N-ethyinicotinamide, detectable in the urine of horses up to 12 hours after the injection together do not exceed 1% of the original dose. This may be because nikethamide is very rapidly metabolized, and because N-ethylnicotinamide is only an intermediate in the metabolism of nikethamide to nicotinamide, which was not determined because this compound is not extracted by the procedure described. However it is possible that alternative metabolic pathways also exist in the horse such as have been demonstrated for guinea-pigs (10), rats (11) and mice (12, 13, 14, 15) . This needs further investigation.
-I 3. Excretion of both Nikethamide and N-Ethylnicotinamide after Acidification of the Urine.
As already mentioned, the normal pH fluctuations in the range of 6.0-8.8 during the different experiments had no significant influence on the concentration of either nikethamide or N-ethyinicotinamide in the urine.
In order to evaluate the influence of the urinary pH on the excretion of both substances an attempt was made to acidify drastically the urinary pH below 6 by means of ammonium chloride as described above. Therefore horses Nos. 5 and 6 were submitted to an additional experiment (Nos. 5A & 6A) after treatment with ammonium chloride. As can be seen from the results the urinary pH dropped between 5.0 and 5.3 in contrast to the normal values of 6.0-8.6. By comparing the results for the horse 5 with 5A and 6 with 6A respectively it is not possible to conclude that there were distinct changes in the excretion pattern of the original drug and its metabolite, except perhaps that the total amount of nikethamide and N-ethyinicotinamide excreted over the whole experimental period was much higher for horse No. 6 after ammonium chloride treatment than before. instead of the 2 hr observed previously, without the ammonium chloride pretreatment. Again there was no difference in the other horse, No. 5, whether he had had the ammonium chloride pretreatment or not. The one and only similarity for both pairs of experiments was the higher average concentration for the two substances under acidic conditions. However these concentrations were still in the range of the values for the other experiments without acidified urine.
central stimulant amines, the excretion of nikethamide and its metabolite N-ethyinicotinamide in the urine of horses is scarcely influenced by changes in the urinary pH, even when this occurs over a range of more than.3 pH units. The figure between brackets refer to the urinary volume (ml/hrJ.
